s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
D
Exempt (Private) Offering
Filed
Wednesday, December 20, 2023
Accession number
0001140361-23-058486
Documents
primary_doc.xml
D
On sec.gov
Filing index
All files
Complete submission text
SGML header